IHT Wealth Management »

Entrada Therapeutics shares owned by IHT Wealth Management

Quarter-by-quarter ownership of Entrada Therapeutics (TRDA) shares owned by IHT Wealth Management from 13F filings

Historical chart of IHT Wealth Management investment in Entrada Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Entrada Therapeutics held by IHT Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Entrada Therapeutics by IHT Wealth Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $114k 11k 10.28
2025-09-30 $64k 11k 5.80
2025-06-30 $72k 11k 6.72

More positions owned by IHT Wealth Management

Apple (AAPL)
NVIDIA Corporation (NVDA)
Wisdomtree Floating Floatng Rat Trea (USFR)
Tesla Motors (TSLA)
Invesco Qqq Unit Ser 1 (QQQ)
Spdr Portfolio Prtflo S&p500 Vl (SPYV)
Ishares Core Core S&p500 Etf (IVV)
Spdr Portfolio Prtflo S&p500 Gw (SPYG)
Microsoft Corporation (MSFT)
First Trust Ft Vest Fd Of Bu (BUFR)
Amazon (AMZN)
Ishares Russell Russell 2000 Etf (IWM)
Blackrock Etf Trust Ishares Us Equit (DYNF)
Ishares Msci Msci Usa Qlt Fct (QUAL)
ISHARES 20 Plus 20 Yr Tr Bd Etf (TLT)

View all positions for IHT Wealth Management

Top funds holding Entrada Therapeutics

Baker Bros. Advisors
MPM Asset Management
5AM Venture Management
BlackRock
TCG Crossover Management
Vanguard Group
Wellington Management Company
Millennium Management
StepStone
Geode Capital Management
State Street Corporation
Jacobs Levy Equity Management
Citadel Advisors
Acadian Asset Management
Dimensional Fund Advisors

View all funds holding Entrada Therapeutics